01 2Byooviz
02 20Lucentis
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 1,881
2018 Revenue in Millions : 1,709
Growth (%) : 10
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 1,609
2019 Revenue in Millions : 2,034
Growth (%) : -21
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 1,933
2019 Revenue in Millions : 2,086
Growth (%) : -7
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 1,456
2020 Revenue in Millions : 1,531
Growth (%) : -6
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 2,160
2020 Revenue in Millions : 1,933
Growth (%) : 12
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 1,874
2021 Revenue in Millions : 2,160
Growth (%) : -13
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 4
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 1,106
2021 Revenue in Millions : 1,456
Growth (%) : -24
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 32
2022 Revenue in Millions : 4
Growth (%) : 637
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 1,475
2022 Revenue in Millions : 1,874
Growth (%) : -21
LOOKING FOR A SUPPLIER?
